HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$1.85
−4.64%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.48x
- Price / sales
- 0.34x
- Price / cash flow
- -6.07x
Enterprise value
- Enterprise value
- $5.6M
- EV / sales
- 0.42x
- EV / EBITDA
- -7.67x
- EV / EBIT
- -5.63x
- Market cap
- $4.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026